Michael Keefer
Infectious Disease · Rochester, NYNPI 1396778155
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,084 of the $1,458 with a category attached, or 74.4%. Every reported general payment came from a single manufacturer, Astrazeneca UK Limited.
Across 10 payments — averaging $145.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astrazeneca UK Limited$1K
Across 29 payments — averaging $25,035 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$726K
What the payments were for
- Travel & lodging$1,08474%
- Food & beverage$37426%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astrazeneca UK Limited | 10 | $1,458 |
How this compares
$1,458 in reported general payments places this provider in the 75th percentile of 799 infectious disease providers in New York.
Other infectious disease in Rochester
- Ann FalseyRochester$135K
- Edward WalshRochester$86K
- Emil LeshoRochester$68K
- Michael MancenidoRochester$32K
- William ValentiRochester$22K
- Harish MoorjaniBriarcliff Manor$733K
- Sorana Segal MaurerFlushing$598K
- Sian JonesNew York$406K
- Antonio UrbinaNew York$373K
- David BekhorNew York$358K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.